blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1555271

EP1555271 - Peptides useful for diagnosis and therapy of TRP-2+ and/or TRP-1+ tumors [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.10.2006
Database last updated on 05.07.2024
Most recent event   Tooltip20.10.2006Application deemed to be withdrawnpublished on 22.11.2006  [2006/47]
Applicant(s)For all designated states
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
Im Neuenheimer Feld 280
69120 Heidelberg / DE
[N/P]
Former [2005/29]For all designated states
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
Im Neuenheimer Feld 280
69120 Heidelberg / DE
Inventor(s)01 / Schadendorf, Dirk
Weberstrasse 3
68165 Mannheim / DE
02 / Paschen, Annette
Weinheimer Strasse 117
68549 Ilvesheim / DE
03 / Kropshofer, Harald
Hangstrasse 4
79539 Lörrach / DE
 [2005/29]
Representative(s)Schüssler, Andrea
Kanzlei Huber & Schüssler
Truderinger Strasse 246
81825 München / DE
[N/P]
Former [2005/29]Schüssler, Andrea, Dr.
Kanzlei Huber & Schüssler Truderinger Strasse 246
81825 München / DE
Application number, filing date04000772.615.01.2004
[2005/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1555271
Date:20.07.2005
Language:EN
[2005/29]
Search report(s)(Supplementary) European search report - dispatched on:EP14.01.2005
ClassificationIPC:C07K14/705, C07K19/00, C07K16/28, C12N15/12, C12N15/63, G01N33/53, G01N33/68, A61K38/17, A61K39/00, A61K39/395
[2005/29]
CPC:
C07K14/705 (EP); A61K38/00 (EP); A61K39/00 (EP);
C12N2799/021 (EP)
Designated contracting states(deleted) [2006/15]
Former [2005/29]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Peptide zur Diagnose und Behandlung von TRP-2+ und/oder TRP-1+ Tumoren[2005/29]
English:Peptides useful for diagnosis and therapy of TRP-2+ and/or TRP-1+ tumors[2005/29]
French:Peptides utilisés pour le diagnose et traitement des tumeurs TRP-2+ et/ou TRP-1+[2005/29]
Examination procedure21.01.2006Application deemed to be withdrawn, date of legal effect  [2006/47]
21.06.2006Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2006/47]
Fees paidPenalty fee
Penalty fee Rule 85a EPC 1973
28.02.2006AT   M01   Not yet paid
28.02.2006BE   M01   Not yet paid
28.02.2006BG   M01   Not yet paid
28.02.2006CH   M01   Not yet paid
28.02.2006CY   M01   Not yet paid
28.02.2006CZ   M01   Not yet paid
28.02.2006DE   M01   Not yet paid
28.02.2006DK   M01   Not yet paid
28.02.2006EE   M01   Not yet paid
28.02.2006ES   M01   Not yet paid
28.02.2006FI   M01   Not yet paid
28.02.2006FR   M01   Not yet paid
28.02.2006GB   M01   Not yet paid
28.02.2006GR   M01   Not yet paid
28.02.2006HU   M01   Not yet paid
28.02.2006IE   M01   Not yet paid
28.02.2006IT   M01   Not yet paid
28.02.2006LU   M01   Not yet paid
28.02.2006MC   M01   Not yet paid
28.02.2006NL   M01   Not yet paid
28.02.2006PT   M01   Not yet paid
28.02.2006RO   M01   Not yet paid
28.02.2006SE   M01   Not yet paid
28.02.2006SI   M01   Not yet paid
28.02.2006SK   M01   Not yet paid
28.02.2006TR   M01   Not yet paid
Penalty fee Rule 85b EPC 1973
28.02.2006M01   Not yet paid
Additional fee for renewal fee
31.01.200603   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0127295  (DEUTSCHES KREBSFORSCH [DE], et al) [X] 1-19 * page 1 - page 3; figure 3; examples 3,5 *;
 [X]WO0190197  (UNIV AUSTRALIAN [AU], et al) [X] 1-19 * page 89, line 8 - line 13; figure 27; example 3; claims 24-28,56-59 *;
 [X]WO02068653  (IMCLONE SYSTEMS INC [US], et al) [X] 1-19 * the entire document, particularly pages 3,7,8,10,13; SEQ ID NO. 15 and the claims *;
 [X]WO02074788  (US GOV HEALTH & HUMAN SERV [US], et al) [X] 1-19 * page 3, line 25 - page 5, line 6; examples 6-9; claims 1,5,7,13,14,25,36-51 *;
 [X]  - UNIPROT, (19981101), Database accession no. O75767, URL: EBI, XP002295233 [X] 1-6 * column A *
 [A]  - TOULOUKIAN CE ET AL., "Expression of a "Self-"Antigen by Human Tumor Cells Enhances Tumor Antigen-specific CD4+ T-Cell Function", CANCER RESEARCH, (20020915), vol. 62, pages 5144 - 5147, XP002295231 [A] * the whole document *
 [A]  - DAVILA E ET AL., "Generation of Antitumor Immunity by Cytotoxic T Lymphocyte Epitope Peptide Vaccination, CpG-oligodeoxynucleotide Adjuvant, and CTLA-4 Blockade", CANCER RESEARCH, (20030615), vol. 63, pages 3281 - 3288, XP002295232 [A] * the whole document *
 [A]  - WANG R-F & WANG HY, Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells, NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, PAGE(S) 149-154, (200202), ISSN 1087-0156, XP002954302 [A] * the whole document *

DOI:   http://dx.doi.org/10.1038/nbt0202-149
 [T]  - PASCHEN A ET AL., "Use of HLA transgenic mice and predictive algorithms for the identification of a new HLA-DR3 restricted epitope from the TRP2 (Tyrosinase related protein 2) melanoma differentiation antigen", ARCHIVES OF DERMATOLOGICAL RESEARCH, (200402), vol. 295, no. 8-9, page 340, XP008035081 [T] * page P039 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.